Loss of KAI1 expression in gastric cancer

Hepato-Gastroenterology

Volumn 52, Issue 61, 2005, Pages 281-284

  Tsutsumi, Soichi ^a   Shimura, Tatsuo ^a   Morinaga, Nobuhiro ^a   Mochiki, Erito ^a   Asao, Takayuki ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric cancer; KAI1; Metastasis

Indexed keywords

CD82 ANTIGEN; GENE PRODUCT; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENDER; GENE EXPRESSION; GENE LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAI1 GENE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH EPITHELIUM; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; FEMALE; HUMANS; KANGAI-1 PROTEIN; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 14144251445     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC: KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (Washington DC) 1995; 268:884-886.
2. Wright MD, Tomlinson MG: The ins and outs of transmembrane 4 superfamily. Immunol Today 1994; 15:588-595.
3. Ueda T, Ichikawa T, Tamura J, Mikata A, Akakura K, Akimoto S, Imai T, Yoshie O, Shiraishi T, Yatani R, Ito H, Shimazaki J: Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer. Am J Pathol 1996; 149:1435-1440.
4. Hinoda Y, Adachi Y, Takaoka A, Mitsuuchi H, Satoh Y, Itoh F, Kondoh Y, Imai K: Decreased expression of the metastasis suppressor gene KAI1 in gastric cancer. Cancer Lett 1998; 129:229-234.
5. Guo X, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Korc M, Buhler MW: KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastasis. Cancer Res 1996; 56:4876-4880.
6. Adachi M, Taki T, Ieki Y, Huang CL, Higashiyama M, Miyake M: Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 1996; 56:1751-1755.
7. Yang X, Welch DR, Phillips KK, Weissman BE, Wei LL: KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Lett 1997; 119:149-155.
8. Yu Y, Yang JL, Markovic B, Jackson P, Yardley G, Barrett JC, Russell PJ: Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers. Clin Cancer Res 1997; 3:1056-1059.
9. Takada A, Hinoda Y, Satoh S, Adachi Y, Itoh F, Adachi M, Imai K: Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene 1998; 16:1443-1453.
10. Hinoda Y, Adachi Y, Takaoka A, Mitsuuchi H, Satoh Y, Itoh F, Kondoh Y, Imai K: Decreased expression of the metastasis suppressor gene KAI1 in gastric cancer. Decreased expression of the metastasis suppressor gene KAI1 in gastric cancer. Cancer Lett 1998; 129:229-234.
11. Geradts J, Robert M, Birrer MJ, Hendricks D, Abbondanzo SL, Fong KM, Carl BJ, Lombardi DP: Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues. Am J Patrol 1999; 154:1665-1671.
12. Sobin LH, Wittekind CH (Eds.): TNM Classification of Malignant Tumors (5th Edition). International Union Against Cancer (UICC). New York, Wiley, 1997; pp. 59-62.
13. Huang CL, Taki T, Adachi M, Yagita M, Sawada S, Takabayashi A, Inufusa H, Yoshie O, Miyake M: MRP-1/CD9 and KAI1/CD82 expression in normal and various cancer tissues. Int J Oncol 1997; 11:1045-1051.
14. Isozaki H, Fujii K, Nomura E, Mabuchi H, Nishiguchi K, Hara H, Tanigawa N: Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma). Hepatogastroenterology 1999; 46:2669-2672.
15. Hudes GR, Lipsitz S, Grem J, Morrisey M, Weiner L, Kugler JW, Benson A 3rd: A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292). Cancer 1999; 85:290-294.
16. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ: Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 1999; 340:908-914.
17. Liotta LA, Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991; 51:5054s-5059s.
18. Nicolson GL: Tumor and host molecules important in the organ preference of metastasis. Semin Cancer Biol 1991; 2:143-154.
19. Adachi Y, Suematsu T, Shiraishi N, Tanimura H, Morimoto A, Kitano S: Perigastric lymph node status as a prognostic indicator in patients with gastric cancer. Br J Surg 1998; 85:1281-1284.